Table 3.
Baseline characteristics of the patients with stroke (N=22).
| Outcome | Control group (n=11) |
Experimental group (n=11) |
P valuea |
| Male, n (%) | 8 (73) | 5 (46) | .39 |
| Hemorrhage, n (%) | 6 (55) | 5 (46) | .76 |
| Right-side lesion, n (%) | 9 (82) | 10 (91) | .61 |
| Height (cm), mean (SD) | 167.09 (4.46) | 162.72 (5.97) | .19 |
| Weight (kg), mean (SD) | 67.27 (7.93) | 60.54 (9.39) | .52 |
| Age (years), mean (SD) | 52.82 (12.29) | 57.55 (14.22) | .53 |
| Time since stroke (months), mean (SD) | 4.91 (3.21) | 3.81 (3.60) | .93 |
| FMA-LEb, mean (SD) | 18.36 (5.52) | 22.64 (4.61) | .11 |
| MBIc, mean (SD) | 70.91 (16.10) | 70.45 (17.39) | .51 |
| BBSd, mean (SD) | 35.82 (10.32) | 37.73 (8.79) | .62 |
| SLSe time (s), mean (SD) | 1.09 (0.61) | 1.04 (0.61) | .86 |
aAll P values were for paired t tests except for gender (male or female), for which P value was for Fisher test. Statistically significant at P<.05.
bFMA-LE: Fugl-Meyer Assessment for Lower Extremity.
cMBI: Modified Barthel Index.
dBBS: Berg Balance Scale.
eSLS: single-leg stance.